{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Méticilline : Questions médicales les plus fréquentes",
"headline": "Méticilline : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Méticilline : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-11",
"dateModified": "2025-04-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Méticilline"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pénicillines",
"url": "https://questionsmedicales.fr/mesh/D010406",
"about": {
"@type": "MedicalCondition",
"name": "Pénicillines",
"code": {
"@type": "MedicalCode",
"code": "D010406",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.300.750"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Méticilline",
"alternateName": "Methicillin",
"code": {
"@type": "MedicalCode",
"code": "D008712",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Carmen Torres",
"url": "https://questionsmedicales.fr/author/Carmen%20Torres",
"affiliation": {
"@type": "Organization",
"name": "Area de Bioquímica y Biología Molecular, Universidad de La Rioja, Logroño, Spain."
}
},
{
"@type": "Person",
"name": "Eric S Donkor",
"url": "https://questionsmedicales.fr/author/Eric%20S%20Donkor",
"affiliation": {
"@type": "Organization",
"name": "1 Department of Medical Microbiology, University of Ghana, Accra, Ghana."
}
},
{
"@type": "Person",
"name": "Patrick Butaye",
"url": "https://questionsmedicales.fr/author/Patrick%20Butaye",
"affiliation": {
"@type": "Organization",
"name": "School of Veterinary Medicine, Ross University, West Farm 000265, Saint Kitts and Nevis."
}
},
{
"@type": "Person",
"name": "Assia Mairi",
"url": "https://questionsmedicales.fr/author/Assia%20Mairi",
"affiliation": {
"@type": "Organization",
"name": "Laboratoire d'Ecologie Microbienne, FSNV, Université de Bejaia, Bejaia 06000, Algeria."
}
},
{
"@type": "Person",
"name": "Abdelaziz Touati",
"url": "https://questionsmedicales.fr/author/Abdelaziz%20Touati",
"affiliation": {
"@type": "Organization",
"name": "Laboratoire d'Ecologie Microbienne, FSNV, Université de Bejaia, Bejaia 06000, Algeria."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis.",
"datePublished": "2024-06-21",
"url": "https://questionsmedicales.fr/article/38912898",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1212/NXI.0000000000200270"
}
},
{
"@type": "ScholarlyArticle",
"name": "Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/37127323",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3899/jrheum.2022-1135"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of blood-based PRO-C3 testing as a diagnostic marker for staging liver fibrosis: A systematic review and meta-analysis.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37287367",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jgh.16240"
}
},
{
"@type": "ScholarlyArticle",
"name": "Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors.",
"datePublished": "2022-09-20",
"url": "https://questionsmedicales.fr/article/36127336",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-022-33003-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after Transplantation.",
"datePublished": "2024-06-07",
"url": "https://questionsmedicales.fr/article/39116277",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2215/CJN.0000000000000474"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "bêta-Lactames",
"item": "https://questionsmedicales.fr/mesh/D047090"
},
{
"@type": "ListItem",
"position": 6,
"name": "Pénicillines",
"item": "https://questionsmedicales.fr/mesh/D010406"
},
{
"@type": "ListItem",
"position": 7,
"name": "Méticilline",
"item": "https://questionsmedicales.fr/mesh/D008712"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Méticilline - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Méticilline",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Méticilline",
"description": "Comment diagnostiquer une infection résistante à la méticilline ?\nQuels tests sont utilisés pour détecter la résistance à la méticilline ?\nQuels symptômes indiquent une infection à staphylocoque ?\nQuand faut-il suspecter une infection à SARM ?\nQuel rôle joue la culture de sang dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Méticilline",
"description": "Quels sont les symptômes d'une infection à SARM ?\nComment se manifeste une infection cutanée ?\nQuels signes indiquent une infection systémique ?\nLes infections à méticilline provoquent-elles des douleurs ?\nQuels symptômes nécessitent une consultation urgente ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Méticilline",
"description": "Comment prévenir les infections à SARM ?\nLes antibiotiques préventifs sont-ils efficaces ?\nQuel rôle joue la vaccination dans la prévention ?\nComment éviter la propagation en milieu hospitalier ?\nLes soins des plaies aident-ils à prévenir les infections ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Méticilline",
"description": "Quel est le traitement principal des infections à SARM ?\nComment traiter une infection cutanée causée par SARM ?\nLes antibiotiques oraux sont-ils efficaces contre SARM ?\nQuelle est l'importance de l'antibiogramme ?\nPeut-on utiliser la méticilline pour traiter le SARM ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Méticilline",
"description": "Quelles sont les complications possibles d'une infection à SARM ?\nComment une infection à SARM peut-elle affecter le cœur ?\nLes infections à SARM peuvent-elles causer des lésions pulmonaires ?\nQuels risques pour les patients diabétiques ?\nLes infections à SARM peuvent-elles être fatales ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Méticilline",
"description": "Quels sont les principaux facteurs de risque pour SARM ?\nLe partage d'objets personnels augmente-t-il le risque ?\nLes athlètes sont-ils plus à risque d'infection à SARM ?\nLes personnes âgées sont-elles plus vulnérables ?\nLes patients en soins intensifs sont-ils à risque ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection résistante à la méticilline ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cultures bactériennes et des tests de sensibilité aux antibiotiques sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter la résistance à la méticilline ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le test de diffusion sur gélose et le test d'agar de dilution sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection à staphylocoque ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, rougeur, gonflement et douleur au site d'infection sont des signes courants."
}
},
{
"@type": "Question",
"name": "Quand faut-il suspecter une infection à SARM ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "En cas d'infections cutanées récurrentes ou de non-réponse aux antibiotiques classiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la culture de sang dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'identifier la présence de bactéries dans le sang et leur sensibilité."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection à SARM ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des rougeurs, des douleurs, des abcès et parfois de la fièvre."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une infection cutanée ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des rougeurs, des gonflements, de la chaleur et des douleurs."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection systémique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre élevée, frissons, fatigue extrême et confusion peuvent indiquer une infection grave."
}
},
{
"@type": "Question",
"name": "Les infections à méticilline provoquent-elles des douleurs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections peuvent causer des douleurs localisées ou généralisées selon la gravité."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une consultation urgente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme une fièvre élevée, des difficultés respiratoires ou des éruptions cutanées graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections à SARM ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiquer une bonne hygiène, se laver les mains et éviter le partage d'objets personnels."
}
},
{
"@type": "Question",
"name": "Les antibiotiques préventifs sont-ils efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation d'antibiotiques préventifs n'est généralement pas recommandée sans indication."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la vaccination dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin spécifique contre le SARM, mais la vaccination générale aide."
}
},
{
"@type": "Question",
"name": "Comment éviter la propagation en milieu hospitalier ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des protocoles stricts d'hygiène et d'isolement des patients infectés sont essentiels."
}
},
{
"@type": "Question",
"name": "Les soins des plaies aident-ils à prévenir les infections ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon soin des plaies réduit le risque d'infection par des bactéries résistantes."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal des infections à SARM ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections à SARM sont généralement traitées avec des antibiotiques comme la vancomycine."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection cutanée causée par SARM ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des antibiotiques et parfois un drainage chirurgical des abcès."
}
},
{
"@type": "Question",
"name": "Les antibiotiques oraux sont-ils efficaces contre SARM ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains antibiotiques oraux comme la clindamycine peuvent être efficaces selon la sensibilité."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'antibiogramme ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'antibiogramme détermine la sensibilité des bactéries aux antibiotiques, guidant le traitement."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la méticilline pour traiter le SARM ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le SARM est résistant à la méticilline et nécessite d'autres antibiotiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection à SARM ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections profondes, des septicémies et des infections osseuses."
}
},
{
"@type": "Question",
"name": "Comment une infection à SARM peut-elle affecter le cœur ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer une endocardite, une infection des valves cardiaques, potentiellement mortelle."
}
},
{
"@type": "Question",
"name": "Les infections à SARM peuvent-elles causer des lésions pulmonaires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des pneumonies, surtout chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Quels risques pour les patients diabétiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients diabétiques sont plus susceptibles de développer des infections graves à SARM."
}
},
{
"@type": "Question",
"name": "Les infections à SARM peuvent-elles être fatales ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être mortelles, surtout si elles ne sont pas traitées rapidement et correctement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour SARM ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hospitalisation, les interventions chirurgicales et l'immunodépression."
}
},
{
"@type": "Question",
"name": "Le partage d'objets personnels augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le partage d'objets comme les serviettes ou les rasoirs peut favoriser la transmission."
}
},
{
"@type": "Question",
"name": "Les athlètes sont-ils plus à risque d'infection à SARM ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en raison des contacts physiques fréquents et des blessures cutanées potentielles."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles ont un système immunitaire affaibli, ce qui augmente le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les patients en soins intensifs sont-ils à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en raison de leur état de santé fragile et de l'exposition à des bactéries résistantes."
}
}
]
}
]
}
The complement system is known to play a role in multiple sclerosis (MS) pathogenesis. However, its contribution to disease progression remains elusive. The study investigated the role of the compleme...
Sixty-eight patients with PPMS from 12 European MS centers were included in the study. Serum and CSF levels of a panel of complement components (CCs) were measured by multiplex enzyme-linked immunosor...
In short term, CC played little or no role in disability progression. In medium term, an elevated serum C3a/C3 ratio was associated with a higher risk of disability progression (adjusted OR 2.30; 95% ...
Proteins involved in the activation of early complement cascades play a role in disability progression as risk (elevated serum C3a/C3 ratio) or protective (elevated CSF C1q) factors after 6 or more ye...
To analyze complement level variations in systemic lupus erythematosus (SLE) pregnancies, focusing on disease flares and obstetric complications....
SLE pregnancies prospectively followed by multidisciplinary teams from 1987 to 2018 in 2 Italian rheumatology centers were retrospectively analyzed. As reference, pregnancy-modified ranges of normal l...
Two hundred forty-six pregnancies in 172 patients with SLE were analyzed. Eighty-nine percent were live births. Thirty-five flares were recorded in 30 pregnancies (12.2%) and obstetric complications o...
Low C4 at preconception was found to be an independent risk factor for SLE flare during pregnancy. Not only C3 and C4 levels but also their variations should be observed, as their failure to increase ...
With the global increase in chronic liver disease and cirrhosis, there is an increasing need to identify non-invasive biomarkers to measure the severity of disease progression while reducing reliance ...
Articles published until January 6, 2023, were searched in the PubMed, Embase, MEDLINE, Web of Science, and Cochrane Library databases. The Quality Assessment of Diagnostic Accuracy Studies-2 tool was...
Fourteen studies with 4315 patients were included. Summary area under the curve of PRO-C3 for the identification of significant fibrosis (≥ F2) and advanced fibrosis (≥ F3) was 0.80 (95% confidence in...
PRO-C3 demonstrated clinically meaningful diagnostic accuracy when used alone as a non-invasive biomarker for diagnosing the liver fibrosis stage in individuals with viral hepatitis or fatty liver dis...
With the addition of the compstatin-based complement C3 inhibitor pegcetacoplan, another class of complement targeted therapeutics have recently been approved. Moreover, compstatin derivatives with en...
C3 glomerulopathy (C3G), which encompasses C3GN and dense deposit disease (DDD), results from dysregulation of the alternative complement pathway. Data on disease recurrence after kidney transplantati...
We retrospectively analyzed 18 patients with native kidney failure attributed to C3G (12 C3GN and six DDD), who received a kidney transplant from January 2016 to January 2023. Demographic, genetic, cl...
During a median (interquartile range) follow-up period of 37 (18–56) months, C3G recurrence occurred in 16 (89%) patients (11 with C3GN and five with DDD) at a median (interquartile range) of 33 (13–1...
Most of the patients with native kidney failure attributed to C3G developed disease recurrence very early after kidney transplantation, usually with minimal proteinuria, mild histologic alterations, a...
There is a clear need to refine the histological assessment in IgA Nephropathy (IgAN). We sought to investigate the clinical significance of the light microscopy (LM) pattern of glomerular injury and ...
We conducted a retrospective, observational study that included all patients with biopsy-proven primary IgAN that had at least 12 months of follow-up. The LM pattern of glomerular injury was reevaluat...
This cohort included 214 patients with IgAN (mean age, 41.4 ± 12.6 years), with a mean eGFR and median 24-h proteinuria of 55.2 ± 31.5 ml/min/1.73m...
We have shown that the LM pattern of glomerular injury and the intensity of mesangial C3 deposition might stratify more accurately the renal outcome in patients with IgAN....
The aim of this study was to investigate the potential importance of complement system activation, with particular emphasis on the complement alternative pathway (AP), in the pathogenesis of hypertens...
Serum complement C3, complement Factor H (CFH) and AP activation were assessed in 66 participants with established essential hypertension with renal damage (RD). Fifty-nine patients with age- and sex-...
Our study revealed that C3 and AP50 continuously increased from normal to NRD to RD (...
Abnormal activation of complement, particularly complement AP, may be a risk factor for the development and progression of hypertensive renal damage....
Sustained complement activation is an underlying pathologic driver in many inflammatory and autoimmune diseases. Currently approved anti-complement therapies are directed at the systemic blockade of c...
To prepare nanoscale ultrasound contrast agents (Nano-UCAs) and examine the role of their surface charge in complement activation and phagocytosis....
We analyzed serum proteins present in the corona formed on Nano-UCAs and evaluated two important protein markers of complement activation (C3 and SC5b-9). The effect of surface charge on phagocytosis ...
When Nano-UCAs were incubated with human serum, they were opsonized by various blood proteins, especially C3. Highly charged Nano-UCAs, whether positive or negative, were favorably opsonized by comple...
Charged Nano-UCAs show a higher tendency to activated complement system, and are efficiently engulfed by macrophages. The present results provide meaningful insights into the role of the surface charg...
Leptospirosis is an infectious neglected disease estimated to affect more than one million people worldwide each year. The Complement System plays a vital role in eliminating infectious agents. Howeve...